Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Ugeskrift for Laeger
|
February 13, 2026
[Macrophage activation syndrome in a young patient with polymyositis]
Stine Daugaard, Søren Jensen-Fangel, Mads Nyhuus Bendix Rasch, et al.
Ugeskrift for Laeger
|
March 28, 2025
[Acute paraspinal compartment syndrome]
Simone Dalskov, Esben Lægsgaard, Bjørn Borsøe Christensen, et al.
Scandinavian Journal of Immunology
|
December 20, 2022
Galectin-3 interacts with PD-1 and counteracts the PD-1 pathway-driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis
Kathrine Pedersen, Morten Aagaard Nielsen, Kristian Juul-Madsen, et al.
Plos One
|
August 5, 2021
Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis
Lotte Lindgreen Eriksen, Morten Aagaard Nielsen, Tea Lund Laursen, et al.
Rheumatology International
|
May 4, 2026
Scalable synovial fibroblast sources enable reproducible basal synovial organoid formation: an in vitro platform study
Søren Lomholt, Ann Mai Brøndum Holm Øllgaard, Anni Aagaard Madsen, et al.
Scandinavian Journal of Gastroenterology
|
May 24, 2025
Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's disease
Morten Aagaard Nielsen, Mia Bendix, Christian Lodberg Hvas, et al.
Pediatric Research
|
May 25, 2021
Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes
Erdal Sag, Selcan Demir, Maithri Aspari, et al.
Scientific Reports
|
November 13, 2021
Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis
Ditte Køster, Johanne Hovgaard Egedal, Søren Lomholt, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2024
Gal-3 blocks the binding between PD-1 and pembrolizumab
Stinne Ravn Greisen, Mia Bendix, Morten Aagaard Nielsen, et al.
Frontiers in Immunology
|
July 11, 2022
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
Morten Aagaard Nielsen, Kristian Juul-Madsen, John Stegmayr, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Ugeskrift for Laeger
|
February 13, 2026
[Macrophage activation syndrome in a young patient with polymyositis]
Stine Daugaard, Søren Jensen-Fangel, Mads Nyhuus Bendix Rasch, et al.
Ugeskrift for Laeger
|
March 28, 2025
[Acute paraspinal compartment syndrome]
Simone Dalskov, Esben Lægsgaard, Bjørn Borsøe Christensen, et al.
Scandinavian Journal of Immunology
|
December 20, 2022
Galectin-3 interacts with PD-1 and counteracts the PD-1 pathway-driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis
Kathrine Pedersen, Morten Aagaard Nielsen, Kristian Juul-Madsen, et al.
Plos One
|
August 5, 2021
Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis
Lotte Lindgreen Eriksen, Morten Aagaard Nielsen, Tea Lund Laursen, et al.
Rheumatology International
|
May 4, 2026
Scalable synovial fibroblast sources enable reproducible basal synovial organoid formation: an in vitro platform study
Søren Lomholt, Ann Mai Brøndum Holm Øllgaard, Anni Aagaard Madsen, et al.
Scandinavian Journal of Gastroenterology
|
May 24, 2025
Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's disease
Morten Aagaard Nielsen, Mia Bendix, Christian Lodberg Hvas, et al.
Pediatric Research
|
May 25, 2021
Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes
Erdal Sag, Selcan Demir, Maithri Aspari, et al.
Scientific Reports
|
November 13, 2021
Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis
Ditte Køster, Johanne Hovgaard Egedal, Søren Lomholt, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2024
Gal-3 blocks the binding between PD-1 and pembrolizumab
Stinne Ravn Greisen, Mia Bendix, Morten Aagaard Nielsen, et al.
Frontiers in Immunology
|
July 11, 2022
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
Morten Aagaard Nielsen, Kristian Juul-Madsen, John Stegmayr, et al.
Page
of 2